New FIGO 2023 Staging System of Endometrial Cancer: An Updated Review on a Current Hot Topic
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064173%3A_____%2F25%3A43928033" target="_blank" >RIV/00064173:_____/25:43928033 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/25:10491592 RIV/00216208:11120/25:43928033 RIV/00064165:_____/25:10491592
Result on the web
<a href="https://doi.org/10.1055/a-2494-8395" target="_blank" >https://doi.org/10.1055/a-2494-8395</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1055/a-2494-8395" target="_blank" >10.1055/a-2494-8395</a>
Alternative languages
Result language
angličtina
Original language name
New FIGO 2023 Staging System of Endometrial Cancer: An Updated Review on a Current Hot Topic
Original language description
The International Federation of Gynaecology and Obstetrics (FIGO) introduced a new staging system for endometrial carcinoma FIGO 2023 in June 2023. The new staging system differs significantly from previous versions by incorporating other non-anatomical parameters (histological type of tumour, tumour grade and the presence of massive lymphovascular space involvement as well as the molecular classification of the tumour). The FIGO 2023 staging system enhances the accuracy of prognostic assessments for patients at a specific stage with better options for targeted treatment. Another objective was to synchronise staging as much as possible with the European oncogynaecological ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma established in 2021. However, several changes are controversial. Routine molecular classification of endometrial carcinomas is not yet commonly available in most countries of the world. Another limitation of the FIGO 2023 staging system of endometrial cancer is the inclusion of variables whose definitions are still evolving, as well as variables that are subject to considerable interobserver variability in their assessment. Advantages, controversies, and limitations for clinical practice of the new FIGO 2023 endometrial cancer staging system are discussed.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
<a href="/en/project/NW24-09-00505" target="_blank" >NW24-09-00505: Molecular classification in relation to prevention of endometrial cancer recurrence and lifestyle factors</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Geburtshilfe und Frauenheilkunde
ISSN
0016-5751
e-ISSN
1438-8804
Volume of the periodical
85
Issue of the periodical within the volume
4
Country of publishing house
DE - GERMANY
Number of pages
12
Pages from-to
405-416
UT code for WoS article
001398153500001
EID of the result in the Scopus database
2-s2.0-85216348336